📊 MRSH Key Takeaways
Is Marsh & Mclennan Companies, Inc.. (MRSH) a Good Investment?
Marsh & McLennan demonstrates strong fundamental business quality with robust profitability margins (23.1% operating, 15.4% net) and exceptional returns on equity (27.2%), supported by solid revenue growth of 10.3% YoY. The company generates substantial free cash flow of $5.0B annually with an 18.5% FCF margin, providing financial flexibility despite elevated leverage, while strong interest coverage of 39.1x indicates manageable debt servicing.
Strong top-line growth, high operating margins, and excellent free cash flow conversion indicate a durable, asset-light model with disciplined capital needs. While net income dipped slightly YoY, EPS still grew and interest coverage is very strong, suggesting manageable leverage and resilient profitability.
Why Buy Marsh & Mclennan Companies, Inc.. Stock? MRSH Key Strengths
- Exceptional profitability with 15.4% net margin and 27.2% ROE, demonstrating efficient capital deployment
- Strong cash generation with $5.0B free cash flow (18.5% FCF margin) providing financial flexibility
- Solid revenue growth of 10.3% YoY combined with stable operating leverage at 23.1% operating margin
- Fortress balance sheet quality evidenced by 39.1x interest coverage ratio despite 1.28x debt-to-equity
- 23% operating margin with double-digit revenue growth
- Robust FCF ($5.0B) and 18.5% FCF margin with low capex
- High ROE (27.2%) and strong interest coverage (39.1x)
MRSH Stock Risks: Marsh & Mclennan Companies, Inc.. Investment Risks
- Elevated financial leverage at 1.28x debt-to-equity with $19.6B long-term debt requiring management focus on deleveraging
- Tight liquidity position with current ratio of 1.10x leaves limited margin for operational disruptions
- Net income declined 1.7% YoY despite 10.3% revenue growth, suggesting margin compression or operational challenges that warrant investigation
- Margin pressure evidenced by slight YoY net income decline
- Moderate leverage (1.28x D/E) could bite if rates or M&A rise
- Exposure to macro/insurance pricing cycles impacting client spend
Key Metrics to Watch
- Operating margin trend and sustainability given net income compression despite revenue growth
- Debt-to-equity ratio trajectory and cash flow allocation toward deleveraging versus capital returns
- Free cash flow conversion and capital expenditure intensity as percentage of revenue
- Operating margin trend
- Organic revenue growth
Marsh & Mclennan Companies, Inc.. (MRSH) Financial Metrics & Key Ratios
💡 AI Analyst Insight
Marsh & Mclennan Companies, Inc.. presents a mixed fundamental picture. Review the detailed metrics above to form your own investment thesis.
MRSH Profit Margin, ROE & Profitability Analysis
MRSH vs Finance Sector: How Marsh & Mclennan Companies, Inc.. Compares
How Marsh & Mclennan Companies, Inc.. compares to Finance sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is Marsh & Mclennan Companies, Inc.. Stock Overvalued? MRSH Valuation Analysis 2026
Based on fundamental analysis, Marsh & Mclennan Companies, Inc.. has mixed fundamental signals relative to the Finance sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
Marsh & Mclennan Companies, Inc.. Balance Sheet: MRSH Debt, Cash & Liquidity
MRSH Revenue & Earnings Growth: 5-Year Financial Trend
5-Year Trend Summary: Marsh & Mclennan Companies, Inc..'s revenue has grown significantly by 10% over the 5-year period, indicating strong business expansion. The most recent EPS of $7.53 reflects profitable operations.
MRSH Revenue Growth, EPS Growth & YoY Performance
MRSH Quarterly Earnings & Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q1 2026 | $7.1B | $1.1B | $2.36 |
| Q3 2025 | $5.7B | $747.0M | $1.51 |
| Q2 2025 | $6.2B | $1.1B | $2.27 |
| Q1 2025 | $6.5B | $1.4B | $2.79 |
| Q3 2024 | $5.4B | $730.0M | $1.47 |
| Q2 2024 | $5.9B | $1.0B | $2.07 |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
Marsh & Mclennan Companies, Inc.. Dividends, Buybacks & Capital Allocation
MRSH SEC Filings: Latest 10-K & 10-Q Analysis
Access official SEC EDGAR filings for Marsh & Mclennan Companies, Inc.. (CIK: 0000062709)
📋 Recent SEC Filings
❓ Frequently Asked Questions about MRSH
What is the AI rating for MRSH?
Marsh & Mclennan Companies, Inc.. (MRSH) has a Combined AI Rating of BUY from Claude (BUY) and ChatGPT (BUY) with 82% combined confidence, based on fundamental analysis of SEC EDGAR filings.
What are MRSH's key strengths?
Claude: Exceptional profitability with 15.4% net margin and 27.2% ROE, demonstrating efficient capital deployment. Strong cash generation with $5.0B free cash flow (18.5% FCF margin) providing financial flexibility. ChatGPT: 23% operating margin with double-digit revenue growth. Robust FCF ($5.0B) and 18.5% FCF margin with low capex.
What are the risks of investing in MRSH?
Claude: Elevated financial leverage at 1.28x debt-to-equity with $19.6B long-term debt requiring management focus on deleveraging. Tight liquidity position with current ratio of 1.10x leaves limited margin for operational disruptions. ChatGPT: Margin pressure evidenced by slight YoY net income decline. Moderate leverage (1.28x D/E) could bite if rates or M&A rise.
What is MRSH's revenue and growth?
Marsh & Mclennan Companies, Inc.. reported revenue of $27.0B.
Does MRSH pay dividends?
Marsh & Mclennan Companies, Inc.. pays dividends, with $1,699.0M distributed to shareholders in the trailing twelve months.
Where can I find MRSH SEC filings?
Official SEC filings for Marsh & Mclennan Companies, Inc.. (CIK: 0000062709) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is MRSH's EPS?
Marsh & Mclennan Companies, Inc.. has a diluted EPS of $8.43.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined rating reflects both perspectives for balanced insights.
Is MRSH a good stock to buy right now?
Based on our AI fundamental analysis in April 2026, Marsh & Mclennan Companies, Inc.. has a BUY rating with 82% confidence. The AI analysis suggests favorable fundamentals based on SEC filings. This is not investment advice.
Is MRSH stock overvalued or undervalued?
Valuation metrics for MRSH: ROE of 27.2% (sector avg: 12%), net margin of 15.4% (sector avg: 25%). Higher ROE suggests strong returns relative to peers.
Should I buy MRSH stock in 2026?
Our dual AI analysis gives Marsh & Mclennan Companies, Inc.. a combined BUY rating for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.
What is MRSH's free cash flow?
Marsh & Mclennan Companies, Inc..'s operating cash flow is $5.3B, with capital expenditures of $291.0M. FCF margin is 18.5%.
How does MRSH compare to other Finance stocks?
Vs Finance sector averages: Net margin 15.4% (avg: 25%), ROE 27.2% (avg: 12%), current ratio 1.10 (avg: 1.2).
Why is MRSH's return on equity (ROE) so high?
Marsh & Mclennan Companies, Inc.. has a return on equity of 27.2%, significantly above the Finance sector average of 12%. A high ROE indicates the company is efficient at generating profits from shareholder equity. This is supported by a 15.4% net margin.